news_6

Regenacy Announces the Formation of a Joint Venture with 3E Bioventures to Develop Ricolinostat in China and the Start of a U.S. Phase 2 Study in Painful Diabetic Peripheral Neuropathy

WALTHAM, Mass.--(BUSINESS WIRE)--Regenacy Pharmaceuticals, a clinical-stage biopharmaceutical company developing breakthrough treatments for diabetic and other peripheral neuropathies, and 3E Bioventures...

news_6

Legend Biotech Announces Initiation of Rolling Submission of Biologics License Application to U.S. FDA Seeking Approval of BCMA CAR-T Therapy Cilta-cel for the Treatment of Relapsed and/or Refractory Multiple Myeloma

Legend Biotech also achieves fifth milestone payment under its collaboration agreement with Janssen in clinical development of cilta-cel SOMERSET, N.J.--(BUSINESS...

news_6

Hand Sanitizer Market in India to Grow by $ 405.31 During 2020-2024 | Industry Analysis, Market Trends, Market Growth, Opportunities and Forecast 2024 | Technavio

LONDON--(BUSINESS WIRE)--#HandSanitizerMarketinIndia--Technavio has been monitoring the hand sanitizer market in India and it is poised to grow by $ 405.31...